148 related articles for article (PubMed ID: 32171109)
21. Stereotactic Body Radiation Therapy for Patients With Sacral Chordoma Who Previously Received Carbon Ion Therapy.
Ito K; Ogawa H
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1263-1264. PubMed ID: 34273319
[No Abstract] [Full Text] [Related]
22. Diffusion-weighted MRI of the lung at 3T evaluated using echo-planar-based and single-shot turbo spin-echo-based acquisition techniques for radiotherapy applications.
Tyagi N; Cloutier M; Zakian K; Deasy JO; Hunt M; Rimner A
J Appl Clin Med Phys; 2019 Jan; 20(1):284-292. PubMed ID: 30421496
[TBL] [Abstract][Full Text] [Related]
23. Role of intraoperative radiotherapy in the treatment of sacral chordoma.
Jullien-Petrelli AC; García-Sabrido JL; Orue-Echebarria MI; Lozano P; Álvarez A; Serrano J; Calvo FM; Calvo-Haro JA; Lasso JM; Asencio JM
Spine J; 2018 Apr; 18(4):632-638. PubMed ID: 28882523
[TBL] [Abstract][Full Text] [Related]
24. Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome.
Anzidei M; Napoli A; Sacconi B; Boni F; Noce V; Di Martino M; Saba L; Catalano C
Radiol Med; 2016 Dec; 121(12):905-915. PubMed ID: 27567615
[TBL] [Abstract][Full Text] [Related]
25. Role of diffusion-weighted MRI in recurrent rectal cancer treated with carbon ion radiotherapy.
Fontana G; Barcellini A; Boccuzzi D; Pecorilla M; Loap P; Cobianchi L; Vitolo V; Fiore MR; Vai A; Baroni G; Preda L; Imparato S; Orlandi E
Future Oncol; 2022 Jul; 18(22):2403-2412. PubMed ID: 35712914
[TBL] [Abstract][Full Text] [Related]
26. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
[TBL] [Abstract][Full Text] [Related]
27. The role of whole-lesion apparent diffusion coefficient analysis for predicting outcomes of prostate cancer patients on active surveillance.
Tamada T; Dani H; Taneja SS; Rosenkrantz AB
Abdom Radiol (NY); 2017 Sep; 42(9):2340-2345. PubMed ID: 28396920
[TBL] [Abstract][Full Text] [Related]
28. Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials.
Imai R; Kamada T; Tsuji H; Sugawara S; Serizawa I; Tsujii H; Tatezaki S;
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1470-6. PubMed ID: 19939576
[TBL] [Abstract][Full Text] [Related]
29. The role of diffusion-weighted MRI (DWI) in the differentiation of benign from malignant skeletal lesions of the pelvis.
Douis H; Davies MA; Sian P
Eur J Radiol; 2016 Dec; 85(12):2262-2268. PubMed ID: 27842675
[TBL] [Abstract][Full Text] [Related]
30. Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma.
Chen Y; Liu X; Zheng D; Xu L; Hong L; Xu Y; Pan J
Magn Reson Imaging; 2014 Jul; 32(6):630-7. PubMed ID: 24703576
[TBL] [Abstract][Full Text] [Related]
31. Role of the Apparent Diffusion Coefficient as a Predictor of Tumor Progression in Patients with Chordoma.
Sasaki T; Moritani T; Belay A; Capizzano AA; Sato SP; Sato Y; Kirby P; Ishitoya S; Oya A; Toda M; Takahashi K
AJNR Am J Neuroradiol; 2018 Jul; 39(7):1316-1321. PubMed ID: 29724767
[TBL] [Abstract][Full Text] [Related]
32. Surgical Treatment of Sacral Chordoma: En Bloc Resection with Negative Margins is a Determinant of the Long-Term Outcome.
Colangeli S; Muratori F; Bettini L; Frenos F; Totti F; D'Arienzo A; Campo FR; Scoccianti G; Beltrami G; Campanacci DA; Capanna R
Surg Technol Int; 2018 Nov; 33():343-348. PubMed ID: 30204925
[TBL] [Abstract][Full Text] [Related]
33. Carbon ion radiotherapy for unresectable sacral chordomas.
Imai R; Kamada T; Tsuji H; Yanagi T; Baba M; Miyamoto T; Kato S; Kandatsu S; Mizoe JE; Tsujii H; Tatezaki S;
Clin Cancer Res; 2004 Sep; 10(17):5741-6. PubMed ID: 15355901
[TBL] [Abstract][Full Text] [Related]
34. Histogram Analysis of Diffusion-Weighted MR Imaging as a Biomarker to Predict Survival of Surgically Treated Colorectal Cancer Patients.
Takahashi Y; Hayano K; Ohira G; Imanishi S; Hanaoka T; Watanabe H; Hirata A; Kawasaki Y; Miyauchi H; Matsubara H
Dig Dis Sci; 2021 Apr; 66(4):1227-1232. PubMed ID: 32409951
[TBL] [Abstract][Full Text] [Related]
35. Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordoma.
Mima M; Demizu Y; Jin D; Hashimoto N; Takagi M; Terashima K; Fujii O; Niwa Y; Akagi T; Daimon T; Hishikawa Y; Abe M; Murakami M; Sasaki R; Fuwa N
Br J Radiol; 2014 Jan; 87(1033):20130512. PubMed ID: 24288399
[TBL] [Abstract][Full Text] [Related]
36. Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient: Preliminary Results From a Single-center Study.
Wu C; Huang J; Xu WB; Guan YJ; Ling HW; Mi JQ; Yan H
Acad Radiol; 2018 Jul; 25(7):904-914. PubMed ID: 29373210
[TBL] [Abstract][Full Text] [Related]
37. ADC value and diffusion tensor imaging of prostate cancer: changes in carbon-ion radiotherapy.
Takayama Y; Kishimoto R; Hanaoka S; Nonaka H; Kandatsu S; Tsuji H; Tsujii H; Ikehira H; Obata T
J Magn Reson Imaging; 2008 Jun; 27(6):1331-5. PubMed ID: 18504751
[TBL] [Abstract][Full Text] [Related]
38. Apparent diffusion coefficient as a prognostic factor in clival chordoma.
Oh HC; Hong CK; Lee KS; Cha YJ; Ahn SJ; Suh SH; Park HH
Sci Rep; 2021 Jan; 11(1):486. PubMed ID: 33436803
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcoma in Older Patients.
Kinoshita H; Yonemoto T; Yamada S; Imai R
Anticancer Res; 2024 Apr; 44(4):1773-1780. PubMed ID: 38537982
[TBL] [Abstract][Full Text] [Related]
40. Chordoma: long-term follow-up after radical photon irradiation.
Catton C; O'Sullivan B; Bell R; Laperriere N; Cummings B; Fornasier V; Wunder J
Radiother Oncol; 1996 Oct; 41(1):67-72. PubMed ID: 8961370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
